Evidence map›Paper›PMID 32330169›Full record

ArticlePloS one2020

Efficacy of chitosan-based nanoparticle vaccine administered to broiler birds challenged with Salmonella.

Keila Y Acevedo-Villanueva, Bailey Lester, Sankar Renu, Yi Han, Revathi Shanmugasundaram, Renukaradhya Gourapura, Ramesh Selvaraj

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. A Novel Approach againstVaccines · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Keila Y Acevedo-VillanuevaDepartment of Poultry Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-4164-7658
Bailey LesterDepartment of Poultry Sciences, University of Georgia, Athens, Georgia, United States of America.
Sankar RenuFood Animal Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio, United States of America.
Yi HanFood Animal Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio, United States of America.
Revathi ShanmugasundaramDepartment of Poultry Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0003-0546-6902
Renukaradhya GourapuraFood Animal Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio, United States of America.
Ramesh SelvarajDepartment of Poultry Sciences, University of Georgia, Athens, Georgia, United States of America.
University of Georgia · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two experiments were conducted to evaluate the immune response of broilers vaccinated with Salmonella chitosan-nanoparticle (CNP) vaccine and challenged with Salmonella. The Salmonella CNP vaccine was synthesized with Salmonella enterica outer membrane proteins (OMPs) and flagellin proteins. In Experiment I, birds were orally gavaged with PBS or 500, 1000, or 2000μg of CNP vaccine 1 and 7d-of-age. At 14d-of-age, birds were orally challenged with 1 X 105 CFU/bird of live S. Enteritidis (SE). Macrophage-nitrite production 11d-post-challenge was higher (P<0.05) in the 500μg group when compared to the control. At d14 (8h-post-challenge), broilers vaccinated with 1000μg CNP had higher (P<0.05) serum anti-OMPs IgG and IgA and cloacal anti-OMP IgA amounts. At 11d-post-challenge, birds vaccinated with 1000μg CNP vaccine had greater (P<0.05) bile anti-OMP and anti-flagellin IgA amounts. At 11d-post-challenge, birds administered 1000μg CNP vaccine has increased (P<0.05) IL-1β and IL-10 mRNA in cecal tonsils. In Experiment II, birds were orally gavaged with PBS or 1000μg CNP or a live commercial vaccine at 1 and 7d-of-age. At 14d-of-age, birds were orally challenged with 1 X 105 CFU/bird of live SE or S. Heidelberg (SH). Birds vaccinated with CNP showed higher (P<0.05) serum anti-OMPs IgG amounts at 8h-post-challenge. At 4d-post-SH challenge, birds vaccinated with CNP had higher (P<0.05) bile anti-flagellin IgA amounts. CNP decreased (P<0.05) anti-OMPs IgG levels in serum at 2d-post-SE challenge and 4d-post-SH or SE challenge. Salmonella Enteritidis loads in cecal content at 2d-post-challenge was decreased (P<0.05) by 65.9% in birds vaccinated with CNP, when compared to the control. Chitosan-nanovaccine had no adverse effects on bird's production performance. In conclusion, 1000μg CNP vaccine can induce a specific immune response against Salmonella and has the potential to mitigate SE cecal colonization in broiler birds.

Indexed as

AnimalsBacterial Outer Membrane ProteinsCecumChickensChitosanFlagellinHistocompatibility Antigens Class IINanoparticlesPoultry DiseasesSalmonellaSalmonella entericaSalmonella enteritidisSalmonella Infections, AnimalSalmonella VaccinesVaccinesVaccines, AttenuatedBacterial Outer Membrane ProteinsChitosanFlagellinHistocompatibility Antigens Class IISalmonella VaccinesVaccinesVaccines, Attenuated

Identifiers

PMID32330169
PMCPMC7182187
OpenAlexW3017537265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.